Cite
HARVARD Citation
Redana, S. et al. (2017). Pathologic Response Rates Following Neoadjuvant Anthracycline and Taxane-based Chemotherapy for Early Breast Cancer (EBC). Clinical oncology. 29 (6), pp. e103-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Redana, S. et al. (2017). Pathologic Response Rates Following Neoadjuvant Anthracycline and Taxane-based Chemotherapy for Early Breast Cancer (EBC). Clinical oncology. 29 (6), pp. e103-. [Online].